| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.017 | 0.9 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |